Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Direxion S&P Biotech Bull 3X (LABU)

45.33   2.03 (4.69%) 02-28 16:00
Open: 39.5 Pre. Close: 43.3
High: 45.53 Low: 39.18
Volume: 3,100,337 Market Cap: 0M
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 45.54 - 45.861 45.861 - 46.11
Low: 38.671 - 38.971 38.971 - 39.204
Close: 44.914 - 45.443 45.443 - 45.853

Technical analysis

as of: 2020-02-28 4:30:09 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 62.57     One year: 72.94
Support: Support1: 39.20    Support2: 32.61
Resistance: Resistance1: 53.57    Resistance2: 62.45
Pivot: 55.76
Moving Average: MA(5): 48.03     MA(20): 55.09
MA(100): 49.48     MA(250): 47.56
MACD: MACD(12,26): -1.83     Signal(9): -0.15
Stochastic oscillator: %K(14,3): 12.73     %D(3): 12.87
RSI: RSI(14): 35.56
52-week: High: 66.46  Low: 27.01  Change(%): -27.1
Average Vol(K): 3-Month: 174452  10-Days: 203733

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
LABU has closed above bottom band by 6.2%. Bollinger Bands are 90.1% wider than normal. The large width of the bands suggest high volatility as compared to LABU's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

2020-02-10
3 Leveraged Healthcare ETFs Soaring This Month
The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidemic. Predictably, the coronavirus outbreak is slamming an array of asset classes, but it's also providing a predictable lift to some healthcare stocks and the related exchange-traded funds. The “Wuhan virus” is also providing an ideal opportunity for active traders to capitalize on opportunities with leveraged healthcare ETFs. What follows are some geared healthcare ETFs that are enjoying fabulous February's and may have more in store over the next couple of weeks. Direxion Daily S&P Biotech Bull 3X Shares (LABU) Speculation is swirling that some smaller biotechnology companies could be somewhat close to getting coronavirus treatments to market (close means several months away) and that's lifting the Direxion Daily S&P Biotech … Full story available on Benzinga.com

2019-06-19
A Beloved Biotech ETF Could Lure Traders Again
With biotechnology stocks and the related exchange-traded funds recently showing some signs of life, it could be just a matter of time before aggressive traders embraced leveraged healthcare ETFs . What Happened The Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU ) is one of the premier avenues for juicing short-term biotechnology returns and the triple-leveraged fund is doing just that with a gain of 21.21% over the past week. LABU is designed to deliver triple the daily returns of the S&P Biotechnology Select Industry Index (SPSIBITR), an equal-weight index. Why It's Important As Monday's news of Pfizer Inc. (NYSE: PFE ) acquiring Array BioPharma (NASDAQ: ARRY ) indicates, there remains robust appetite among larger, … Full story available on Benzinga.com

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE Arca
Sector: 
Industry: 
Shares Out. (M) 13.26
Shares Float (M) 13.26
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
Book Value (p.s.) 4.500
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -23.7
Return on Equity (ttm) -19.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E
P/E Growth Ratio
P/BV 10.08
P/S
P/CF

Dividends & Splits

Dividend 0.450
Dividend Yield 0.01
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.